Contrast-Enhanced Ultrasound Applications in Hepatic Imaging

Contrast-enhanced ultrasound (CEUS) has emerged as a versatile, real-time imaging modality for the evaluation of focal liver lesions, vascular architecture, and treatment response in hepatic disease. By administering gas-filled microbubbles that remain strictly intravascular, CEUS affords dynamic assessment of tumour perfusion from the arterial through the late phases without ionising radiation or nephrotoxic contrast. Its high temporal resolution enables precise characterisation of arterial hyperenhancement patterns, wash-out kinetics and tissue stiffness when combined with shear wave elastography. CEUS supports non-invasive differentiation of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and benign nodules, guides percutaneous ablation and biopsy, and permits early evaluation of residual disease after locoregional therapies. Integration into standardised reporting systems and its favourable safety profile have driven global adoption, improving diagnostic confidence, patient stratification and cost-effectiveness in hepatic practice.

Research from Nature Portfolio

A comprehensive analysis investigated how cellular differentiation and tumour size influence CEUS enhancement patterns in hepatocellular carcinoma. In a large cohort of surgically confirmed cases, poorly differentiated tumours and lesions larger than 3 cm showed more inhomogeneous arterial enhancement and earlier wash-out, while well differentiated and smaller lesions exhibited delayed or absent wash-out. Quantitative measurement of wash-in and wash-out times revealed a gradation correlating with histological grade, suggesting that CEUS dynamic parameters can serve as non-invasive biomarkers of tumour biology. Importantly, underlying hepatic background did not significantly alter enhancement kinetics, underscoring the robustness of CEUS for characterising HCC across varying parenchymal conditions.

Contrast-Enhanced Ultrasound Applications in Hepatic Imaging publication trend

The graph below shows the total number of articles in contrast-enhanced ultrasound applications in hepatic imaging across all publications each year (not limited to Nature Index journals).

Technical terms

Contrast-enhanced ultrasound (CEUS): Ultrasonographic technique using intravascular microbubbles to visualise real-time vascular perfusion.

Hyperenhancement: Increased echogenicity of a lesion during the arterial phase relative to surrounding liver tissue.

Wash-out: Progressive reduction in lesion enhancement in portal or late vascular phases, often indicating malignancy.

LI-RADS: Liver Imaging Reporting and Data System, a structured framework for categorising liver lesions on imaging.

Shear wave elastography (SWE): Ultrasound method measuring tissue stiffness by tracking shear wave propagation.

Perfusion: Distribution and movement of contrast through microvascular networks within the liver parenchyma.

References

1. Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors. International Journal of Molecular Sciences (2023).
2. Detailed Analysis of Temporal Features on Contrast Enhanced Ultrasound May Help Differentiate Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma in Cirrhosis. PLOS ONE (2014).
3. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights into Imaging (2014).
4. Contrast-enhanced ultrasound (CEUS) in abdominal intervention. Abdominal Radiology (2018).
5. Perfusion Characteristics of Hepatocellular Carcinoma at Contrast-enhanced Ultrasound: Influence of the Cellular differentiation, the Tumor Size and the Underlying Hepatic Condition. Scientific Reports (2018).
6. Usefulness of Modified CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma Using Sonazoid. Diagnostics (2020).
7. Use of CEUS LI-RADS for the Accurate Diagnosis of Nodules in Patients at Risk for Hepatocellular Carcinoma: A Validation Study. Radiology Imaging Cancer (2020).